INTEGRATING IMMUNITY AND GENETICS IN FOLLICULAR LYMPHOMA TO ESTABLISH A PROGNOSTIC SCORE FIT FOR THE MODERN ERA
Grant number: 1142980 | Funding period: 2018 - 2021
Follicular lymphoma (FL) is divided into early and advanced stages. Early stage FL is frequently cured, but there is no way to identify who will be cured and who won't. By contrast advanced stage FL is incurable. Our unique access to well-annotated clinical trial and population based cohorts allows us to perform a detailed biological comparison of early and advanced FL, to gain a deeper understanding of the impediments to eradicating the disease, and to predict outcome to conventional therapy.